Trevena Reports Promising Q3 2023 Results, Reveals Progress in TRV045 Studies and OLINVYK Sales - MyChesCo
Trevena highlights promising Q3 2023 results, showcasing advancements in TRV045 studies and OLINVYK sales. Stay updated on the latest developments in pharmaceuticals.
Timothy Alexander
